Cargando…
R3-AFP score is a new composite tool to refine prediction of hepatocellular carcinoma recurrence after liver transplantation
BACKGROUND & AIMS: Patients with hepatocellular carcinoma (HCC) are selected for liver transplantation (LT) based on pre-LT imaging ± alpha-foetoprotein (AFP) level, but discrepancies between pre-LT tumour assessment and explant are frequent. Our aim was to design an explant-based recurrence ris...
Autores principales: | Costentin, Charlotte, Piñero, Federico, Degroote, Helena, Notarpaolo, Andrea, Boin, Ilka F., Boudjema, Karim, Baccaro, Cinzia, Podestá, Luis G., Bachellier, Philippe, Ettorre, Giuseppe Maria, Poniachik, Jaime, Muscari, Fabrice, Dibenedetto, Fabrizio, Duque, Sergio Hoyos, Salame, Ephrem, Cillo, Umberto, Marciano, Sebastian, Vanlemmens, Claire, Fagiuoli, Stefano, Burra, Patrizia, Van Vlierberghe, Hans, Cherqui, Daniel, Lai, Quirino, Silva, Marcelo, Rubinstein, Fernando, Duvoux, Christophe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8961219/ https://www.ncbi.nlm.nih.gov/pubmed/35360522 http://dx.doi.org/10.1016/j.jhepr.2022.100445 |
Ejemplares similares
-
AFP score and metroticket 2.0 perform similarly and could be used in a “within-ALL” clinical decision tool
por: Piñero, Federico, et al.
Publicado: (2022) -
International study on the outcome of locoregional therapy for liver transplant in hepatocellular carcinoma beyond Milan criteria
por: Degroote, Helena, et al.
Publicado: (2021) -
AFP
Publicado: (2009) -
Five‐year outcomes in liver transplant patients receiving everolimus with or without a calcineurin inhibitor: Results from the CERTITUDE study
por: Saliba, Faouzi, et al.
Publicado: (2022) -
Status of AFP
por: Erland, Paula Agnieszka
Publicado: (2019)